North America Next Generation Sequencing Ngs Market Companies

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

North America Next Generation Sequencing Ngs Market Companies

  • Healthcare
  • Mar 2024
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Companies Covered

Highest Market Share

Dominant Companies

    Other Companies

    North America Next Generation Sequencing Ngs Market Share Analysis

    Star The data presented is for visualization purposes only and may not reflect actual results.

    Nucleus : Company Analysis Platform

    Frequently Asked Questions

    The market is segmented based on North America Next Generation Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research, Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes, Hospital & Clinics) – Industry Trends and Forecast to 2030. .
    The North America Next Generation Sequencing Ngs Market size was valued at USD 3489.40 USD Million in 2022.
    The North America Next Generation Sequencing Ngs Market is projected to grow at a CAGR of 17.4% during the forecast period of 2023 to 2030.
    The major players operating in the market include Agilent Technologies , ThermoFisher Scientific , QIAGEN, Illumina , Bio-Rad Laboratories , BGI, Oxford Nanopore Technologies plc, Pacific Biosciences of California , 10x Genomics , PerkinElmer , Genewiz, Partek ,orporated, Becton Dickinson and Company, Genomic Health , Guardant Health , Personalis ,.
    The market report covers data from the U.S., Canada, Mexico.